Revolutionizing anticoagulation: DOAC versus VKA in atrial fibrillation with early post-bioprosthetic valves replacement or valves repair
DOACs demonstrated comparable efficacy and safety to VKAs in the early postoperative period after biological valve replacement or repair, suggesting that they may serve as an alternative to VKAs.
Authors
- Qinan Yin (ORCID: https://orcid.org/0000-0001-7837-2259)
- Hao Wang (ORCID: https://orcid.org/0000-0001-6881-9977)
- Yuan Bian (ORCID: https://orcid.org/0000-0002-9695-9384)
- Liuyun Wu
- Fengjiao Kang
- Fei Zeng
- Bo Xiang
- Lizhu Han
- Xuefei Huang
- Yin Wang
Institutions
- University of Electronic Science and Technology of China (CN)
- Xinjiang Medical University (CN)
Publication Details
- Journal
- International Journal of Surgery
- Published
- 2026-02-11
- DOI
- https://doi.org/10.1097/js9.0000000000004470
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00